Characteristic | Baseline | Post-intervention | Mean difference | Effect size | Within group | Between groups P-value |
---|---|---|---|---|---|---|
(95%CI) | (Power) | P- value | (Post-intervention) | |||
Adiponectin (ng ml-1) | Â | Â | Â | Â | Â | 0.985 |
HIT (37) | 9.4 ± 6.1 | 7.6 ± 6.5 | 1.8 (-4.4 to 0.8) |  | 0.162 |  |
Control (46) | 8.1 ± 4.5 | 7.4 ± 6.2 | 0.6 (-2.3 to 1.0) |  | 0.191 | |
CRP (mg L-1) | Â | Â | Â | Â | Â | 0.940 |
HIT (36 | 1.3 ± 1.2 | 1.6 ± 1.7 | 0.4 (-0.2 to 1.1) |  | 0.192 |  |
Control (43) | 1.4 ± 1.4 | 1.6 ± 1.6 | 0.2 (-0.4 to 0.8) |  | 0.459 | |
Glucose (mMol L-1) | Â | Â | Â | Â | Â | 0.517 |
HIT (26) | 4.9 ± 1.3 | 5.0 ± 1.2 | 0.1 (-0.6 to 0.7) |  | 0.836 |  |
Control (38) | 5.0 ± 1.0 | 5.2 ± 1.0 | 0.2 (-0.2 to 0.6) |  | 0.434 | |
HDL (mMol L-1) | Â | Â | Â | Â | Â | 0.694 |
HIT (26) | 1.4 ± 0.3 | 1.8 ± 1.1 | 0.3 (-0.1 to 0.7) |  | 0.167 |  |
Control (36) | 1.4 ± 0.4 | 1.7 ± 1.0 | 0.4 (-0.01 to 0.8) |  | 0.056 | |
Insulin (IU ml-1) | Â | Â | Â | Â | Â | 0.235 |
HIT (24) | 7.9 ± 7.5 | 8.5 ± 11.8 | 0.6 (-5.5 to 6.7) |  | 0.764 |  |
Control (34) | 7.3 ± 4.5 | 5.8 ± 4.2 | 1.5 (-3.6 to 0.6) |  | 0.307 | |
IL-6 (pg ml-1) | Â | Â | Â | Â | Â | 0.495 |
HIT (27) | 3.4 ± 4.1 | 2.9 ± 3.8 | 0.6 (-2.1 to 0.9) |  | 0.788 |  |
Control (40) | 3.8 ± 2.9 | 3.9 ± 7.9 | 0.2 (-2.6 to 2.9) |  | 0.149 | |
LDL (mMol L-1) | Â | Â | Â | Â | Â | 0.402 |
HIT (24) | 2.5 ± 1.5 | 1.5 ± 1.0 | 1.1 (-2.0 to -0.2) | 0.51 (67.6%) | 0.019 |  |
Control (33) | 2.8 ± 1.8 | 1.7 ± 0.8 | 0.9 (-1.6 to -0.3) | 0.51 (80.8%) | 0.006 | |
Total Cholesterol (mMol L-1) | Â | Â | Â | Â | Â | 0.182 |
HIT (28) | 4.5 ± 1.8 | 3.8 ± 1.2 | 0.7 (-1.6 to 0.2) |  | 0.149 |  |
Control (40) | 4.2 ± 1.6 | 3.5 ± 1.3 | 0.7 (-1.5 to -0.05) | 0.34 (56.1%) | 0.036 | |
Triglycerides (mMol L-1) | Â | Â | Â | Â | Â | 0.609 |
HIT (29) | 1.0 ± 0.3 | 1.1 ± 0.4 | 0.1 (-0.1 to 0.3) |  | 0.172 |  |
Control (41) | 1.0 ± 0.4 | 1.1 ± 0.5 | 0.05 (-0.1 to 0.2) |  | 0.526 |